Indian J Pharm Close
 

Figure 3: Diosmin treatment effect on forced swim test (Immobility period; n = 6) and beam walk test (Number of leg slips; n = 6) (a) Immobility period of forced swim test (b) Number of leg slips during beam walk. *P < 0.05 is considered significant in comparison with normal and #P < 0.05 is considered significant in comparison with arsenic control

Figure 3: Diosmin treatment effect on forced swim test (Immobility period; <i>n</i> = 6) and beam walk test (Number of leg slips; <i>n</i> = 6)<b> (</b>a) Immobility period of forced swim test (b) Number of leg slips during beam walk.<b></b> *<i>P </i>< 0.05 is considered significant in comparison with normal and <sup>#</sup><i>P</i> < 0.05 is considered significant in comparison with arsenic control